Open Access. Powered by Scholars. Published by Universities.®
- Keyword
-
- Research and development (2)
- Association for Molecular Pathology v. Myriad Genetics (1)
- Biotechnology (1)
- California Consumer Privacy Act (1)
- Data security (1)
-
- Diseases (1)
- Ethics (1)
- General Data Protection Regulation (1)
- Genetics (1)
- Health care (1)
- Health information (1)
- Healthcare (1)
- In vitro fertilization (1)
- Information (1)
- Mitochonfrial replacement therapy (1)
- Pandemics (1)
- Patent eligibility (1)
- Patent law (1)
- Patient rights (1)
- Public health (1)
- Reproductive technology (1)
- Telemedicine (1)
- United States Supreme Court (1)
Articles 1 - 3 of 3
Full-Text Articles in Law
Mitochondrial Replacement Therapy: Let The Science Decide, Sabrina K. Glavota
Mitochondrial Replacement Therapy: Let The Science Decide, Sabrina K. Glavota
Michigan Technology Law Review
Mitochondrial replacement therapy (MRT) is an in vitro fertilization technique designed to prevent women who are carriers of mitochondrial diseases from passing on these heritable genetic diseases to their children. It is an innovative assisted reproductive technology that is only legal in a small number of countries. The United States has essentially stagnated all opportunities for research and clinical trials on MRT through a rider in H.R.2029 – Consolidated Appropriations Act, 2016. The rider bans clinical trials on all therapies in which a human embryo is intentionally altered to include a heritable genetic modification. This note argues that the rider …
Association For Molecular Pathology V. Myriad Genetics: A Critical Reassessment, Jorge L. Contreras
Association For Molecular Pathology V. Myriad Genetics: A Critical Reassessment, Jorge L. Contreras
Michigan Technology Law Review
The Supreme Court’s 2013 decision in Association for Molecular Pathology v. Myriad Genetics is an essential piece of the Court’s recent quartet of patent eligibility decisions, which also includes Bilski v. Kappos, Mayo v. Prometheus, and Alice v. CLS Bank. Each of these decisions has significantly shaped the contours of patent eligibility under Section 101 of the Patent Act in ways that have been both applauded and criticized. The Myriad case, however, was significant beyond its impact on Section 101 jurisprudence. It was seen, and litigated, as a case impacting patient rights, access to healthcare, scientific freedom, …
Healthy Data Protection, Lothar Determann
Healthy Data Protection, Lothar Determann
Michigan Technology Law Review
Modern medicine is evolving at a tremendous speed. On a daily basis, we learn about new treatments, drugs, medical devices, and diagnoses. Both established technology companies and start-ups focus on health-related products and services in competition with traditional healthcare businesses. Telemedicine and electronic health records have the potential to improve the effectiveness of treatments significantly. Progress in the medical field depends above all on data, specifically health information. Physicians, researchers, and developers need health information to help patients by improving diagnoses, customizing treatments and finding new cures.
Yet law and policymakers are currently more focused on the fact that health …